| RS515726184 |
RRM2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 8a, RRM2B-related mitochondrial disease |
| RS515726185 |
RRM2B
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 8a, Mitochondrial DNA depletion syndrome 8a |
| RS515726186 |
RRM2B
|
Health Risk |
Likely pathogenic |
RRM2B-related mitochondrial disease, Mitochondrial DNA depletion syndrome 8a |
| RS515726189 |
RRM2B
|
Health Risk |
Conflicting classifications of pathogenicity |
RRM2B-related mitochondrial disease, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS515726196 |
RRM2B
|
Health Risk |
Pathogenic/Likely pathogenic |
RRM2B-related mitochondrial disease, Mitochondrial DNA depletion syndrome 8a |
| RS515726199 |
RRM2B
|
Health Risk |
Pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 |
| RS515726201 |
RRM2B
|
Health Risk |
Pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 |
| RS515726204 |
C19orf12
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 4, Hereditary spastic paraplegia 43 |
| RS515726205 |
C19orf12
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 4, Dystonic disorder |
| RS515726209 |
CTRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS515726210 |
CTRC
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Pancreatitis |
| RS515726212 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS515726215 |
SLC12A6
|
Health Risk |
Pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Charcot-Marie-Tooth disease |
| RS515726216 |
SLC12A6
|
Health Risk |
Pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS515726217 |
SLC12A6
|
Health Risk |
Pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS515726218 |
SLC12A6
|
Health Risk |
Pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS515726220 |
GNRHR
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 7 with or without anosmia, Hypogonadotropic hypogonadism 7 with or without anosmia |
| RS515726221 |
POU1F1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS515726223 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS515726224 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hartsfield-Bixler-Demyer syndrome |
| RS515726225 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS515726227 |
MSX1
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS515726229 |
G6PC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS515726231 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS515726232 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS515726233 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS515726234 |
TBX5
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS5174 |
LRP8
|
Health Risk |
risk factor |
Myocardial infarction, susceptibility to |
| RS519650 |
F7
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor VII deficiency, Factor VII deficiency |
| RS5206 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS5208 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS5209 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS521047 |
RERE
|
Health Risk |
Likely pathogenic |
— |
| RS5212 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 13, Diabetes mellitus |
| RS5213 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 13, Hyperinsulinemic hypoglycemia |
| RS5214 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 13, Diabetes mellitus |
| RS5216 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 13, Diabetes mellitus |
| RS5217 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS5218 |
KCNJ11
|
Health Risk |
association not found |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS527236030 |
STIM1
|
Health Risk |
Pathogenic |
Myopathy, tubular aggregate |
| RS527236031 |
PIGT
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 3, Multiple congenital anomalies-hypotonia-seizures syndrome 3 |
| RS527236032 |
PIGT
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 3, Multiple congenital anomalies-hypotonia-seizures syndrome 3 |
| RS527236033 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS527236034 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS527236035 |
MED23
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 18 |
| RS527236036 |
MED23
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 18 |
| RS527236037 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS527236038 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS527236039 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS527236040 |
DARS1
|
Health Risk |
Pathogenic |
Hypomyelination with brain stem and spinal cord involvement and leg spasticity, Hypomyelination with brain stem and spinal cord involvement and leg spasticity |
| RS527236046 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Isolated Nonsyndromic Congenital Heart Disease |
| RS527236048 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Retinal dystrophy |
| RS527236050 |
SPATA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 3, Retinal dystrophy |
| RS527236055 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236056 |
PCARE
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236058 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 49 |
| RS527236059 |
CNGA1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236060 |
CNGB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 45 |
| RS527236061 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236062 |
CRX
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236063 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236065 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS527236066 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS527236067 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236068 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236069 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236070 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236071 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236072 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS527236073 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236074 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236075 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236076 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS527236077 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS527236078 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236079 |
LRAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Leber congenital amaurosis |
| RS527236080 |
MAK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236082 |
MAK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236083 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236084 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 38, Retinitis pigmentosa |
| RS527236085 |
MYO7A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236086 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 37 |
| RS527236087 |
NRL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236088 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 40 |
| RS527236089 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236090 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236091 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236092 |
PRCD
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 36 |
| RS527236094 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236095 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236096 |
PRPF6
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236097 |
PRPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236098 |
PRPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, PRPH2-related disorder |
| RS527236099 |
RDH12
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 53, Retinitis pigmentosa |
| RS527236100 |
RHO
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236101 |
RHO
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 4 |
| RS527236102 |
RHO
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236103 |
RHO
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236105 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236107 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |